Here we took advantage of the natural hypoxia targeting ability of VNP20009 combined with other treatments to improve its anti-cancer efficacy.On the one hand,we collaborated VNP20009 with long-circulating liposomes containing hydroxychloroquine,which could arrest VNP20009-induced autophagy and thereby protected the therapeutic bacteria for tumor inhibition [1].